Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.

Item

http://www.wikidata.org/entity/Q39360350

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Dual targeting of ErbB2 and MU ...... ovide complementary signaling.

@en

Dual targeting of ErbB2 and MU ...... ovide complementary signaling.

@nl

type

Item

label

Dual targeting of ErbB2 and MU ...... ovide complementary signaling.

@en

Dual targeting of ErbB2 and MU ...... ovide complementary signaling.

@nl

prefLabel

Dual targeting of ErbB2 and MU ...... ovide complementary signaling.

@en

Dual targeting of ErbB2 and MU ...... ovide complementary signaling.

@nl

P1476

Dual targeting of ErbB2 and MU ...... rovide complementary signaling

@en

P2093

Ana C Parente Pereira

http://www.w3.org/2001/XMLSchema#string

David M Davies

http://www.w3.org/2001/XMLSchema#string

Scott Wilkie

http://www.w3.org/2001/XMLSchema#string

Sjoukje J C van der Stegen

http://www.w3.org/2001/XMLSchema#string

Sophie E Burbridge

http://www.w3.org/2001/XMLSchema#string

Steve Hobbs

http://www.w3.org/2001/XMLSchema#string

Suzanne A Eccles

http://www.w3.org/2001/XMLSchema#string

P2860

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Human breast cancer cell lines co-express neuronal, epithelial, and melanocytic differentiation markers in vitro and in vivo

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production.

Retroviral-mediated gene transfer in primary murine and human T-lymphocytes.

Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4.

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes.

P2888

s10875-012-9689-9

P304

1059-1070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10875-012-9689-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Maher

Carol Box

May C I Van Schalkwyk

P577

2012-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224819511

http://www.w3.org/2001/XMLSchema#string

P698

22526592

http://www.w3.org/2001/XMLSchema#string